spacer
home > news > detailed info
INDUSTRY NEWS AND PRESS RELEASES

NHS Foundation Trust Signs Collaboration Agreement With Automata To Automate Laboratories

Automata Technologies



University Hospital Southampton (UHS) NHS Foundation Trust has signed a commercial collaboration agreement with Automata to develop new applications for laboratory automation technology.


Automata is a London based biotech company providing robotic automation solutions to the life sciences industry. Comprising proprietary hardware, single-platform software and a world-class service, Automata partners with labs to take the hassle out of automation, empowering them to achieve more reliable results faster than ever before.

Following Automata’s successful implementation of new automated technology as part of the national COVID-19 testing programme response, they are developing their partnership with University Hospital Southampton NHS Foundation Trust (UHS) to explore future clinical use cases in other areas of laboratory medicine.

The partnership aims to optimise Automata's expertise in lab automation at scale, drawing upon UHS as a development partner and reference site.

Martin Gossling, Head of Commercial Innovation at UHS, said: “A key legacy of delivering saliva testing as part of the national COVID-19 response has been how we can apply the automation of processes on a wider scale across the clinical sector. Partnering with Automata has allowed us to combine our knowledge of laboratory work and access to it, with their technological solutions that will ultimately result in more efficient processes at scale that will benefit the NHS and the patients we serve.”

Mostafa ElSayed, CEO & CoFounder Automata adds: “It’s fantastic to be partnering with the NHS to demonstrate how our technology can answer the need for exceptionally reliable solutions that enable scalability, enhance capacity, and empower over-stretched workforces. The whole team at Automata are proud to be helping our amazing NHS scientists achieve better results faster with worry-free lab automation from Automata Labs.”
phone +44 (0) 20 399 12253
email hello@automata.tech
web automata.tech
email 15-29 Windsor St. London N1 8QG
 
Print this page
Send to a friend
   
spacer
News and Press Releases

ETIHAD CARGO EXPANDS OPERATIONS IN CHINA, OFFERING ADDITIONAL BELLY HOLD CAPACITY TO GUANGZHOU

From 10 October, Etihad Cargo will offer 30 tonnes of additional cargo capacity to China with the introduction of twice-weekly passenger services to Guangzhou
More info >>


White Papers

Quality By Design

Biopharma Group

Quality by Design (QbD) is a systematic approach to development that begins with the defined objectives and emphasizes science and quality risk management in order to achieve those goals. QbD ensures that the quality of the product is built into production processes from the outset, rather than being tested after development has already commenced.
More info >>

 
©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement